Trial intelligence / Profile preview

Phase 2 capecitabine (R340) in taxane-pretreated metastatic breast cancer

jRCT2080220019Phase 2

Sponsor

Chugai Pharmaceutical Co., Ltd.

Start

Sep 2005

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules

Countries

1